Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

Abstract The World Health Organization (WHO) advocates population-based screening
programs to reduce the global incidence of cervical cancer. However, screening guidelines …

Background The primary goal of human papillomavirus (HPV) vaccination is to reduce
morbidity and mortality from HPV-associated disease, especially cervical cancer. We …

Background: Each year 604,127 new cases of cervical cancer (CC) are diagnosed, and
341,831 individuals die from the disease. It is the fourth most common cancer among …

Following the global call for action by the World Health Organization to eliminate cervical
cancer (CC), we evaluated how each CC policy decision in Norway influenced the timing of …

Purpose In terms of medical policy for cervical cancer prevention, Japan lags far behind
other industrialized countries. We initiated a randomized controlled trial to evaluate the self …

A self-sampling human papillomavirus (HPV) test could improve the morbidity and mortality
of cervical cancer in Japan. However, its effectiveness and feasibility have not been …

Abstract Background The VALidation of HPV GENoyping Tests (VALGENT) is an
international initiative designed to validate HPV assays with genotyping capability. The …

MicroRNAs (MiRNAs), which are highly conserved and small noncoding RNAs, negatively
regulate gene expression and influence signaling pathways involved in essential biological …

Background Incidence of cervical cancer has been reduced by organized screening while
for vaginal and vulvar cancers no systematic screening has been implemented. All these …